Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,862 | -5,676 | -3,669 | -1,952 | -7,097 |
| Depreciation Amortization | 33 | 24 | 16 | 7 | 52 |
| Income taxes - deferred | 12 | N/A | N/A | N/A | 95 |
| Accounts payable and accrued liabilities | 137 | -151 | -116 | -52 | 147 |
| Other Working Capital | -321 | -771 | -801 | -802 | -2,719 |
| Other Operating Activity | -316 | 966 | 703 | 400 | 1,368 |
| Operating Cash Flow | $-7,317 | $-5,608 | $-3,867 | $-2,400 | $-8,154 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | N/A | N/A | N/A | N/A |
| Net Acquisitions | -111 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -114 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-244 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 278 | 278 | 278 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -5 |
| Common Stock Issued | 5,218 | 4,501 | N/A | 4,501 | 2,150 |
| Other Financing Activity | -499 | 0 | 4,501 | 0 | 1,775 |
| Financing Cash Flow | $4,998 | $4,780 | $4,780 | $4,501 | $3,921 |
| Exchange Rate Effect | -27 | -17 | 0 | 0 | 6 |
| Beginning Cash Position | 3,822 | 3,822 | 3,822 | 3,822 | 8,049 |
| End Cash Position | 1,231 | 2,976 | 4,734 | 5,923 | 3,822 |
| Net Cash Flow | $-2,591 | $-845 | $912 | $2,101 | $-4,228 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,317 | -5,608 | -3,867 | -2,400 | -8,154 |
| Capital Expenditure | -20 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -7,337 | -5,608 | -3,867 | -2,400 | -8,154 |